These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32636193)

  • 1. The role of ISCHEMIA in stable ischemic heart disease.
    Spilias N; Zorach B; Denby K; Ellis S
    Cleve Clin J Med; 2020 Jun; 87(7):401-409. PubMed ID: 32636193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
    ; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
    Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial?
    Cheng-Torres KA; Desai KP; Sidhu MS; Maron DJ; Boden WE
    Future Cardiol; 2016 Jan; 12(1):35-44. PubMed ID: 26696561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design.
    Bangalore S; Maron DJ; Fleg JL; O'Brien SM; Herzog CA; Stone GW; Mark DB; Spertus JA; Alexander KP; Sidhu MS; Chertow GM; Boden WE; Hochman JS;
    Am Heart J; 2018 Nov; 205():42-52. PubMed ID: 30172098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial strategy of revascularization versus optimal medical therapy for improving outcomes in ischemic heart disease: a review of the literature.
    Songco AV; Brener SJ
    Curr Cardiol Rep; 2012 Aug; 14(4):397-407. PubMed ID: 22555943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial.
    Hochman JS; Reynolds HR; Bangalore S; O'Brien SM; Alexander KP; Senior R; Boden WE; Stone GW; Goodman SG; Lopes RD; Lopez-Sendon J; White HD; Maggioni AP; Shaw LJ; Min JK; Picard MH; Berman DS; Chaitman BR; Mark DB; Spertus JA; Cyr DD; Bhargava B; Ruzyllo W; Wander GS; Chernyavskiy AM; Rosenberg YD; Maron DJ;
    JAMA Cardiol; 2019 Mar; 4(3):273-286. PubMed ID: 30810700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
    Shaw LJ; Berman DS; Maron DJ; Mancini GB; Hayes SW; Hartigan PM; Weintraub WS; O'Rourke RA; Dada M; Spertus JA; Chaitman BR; Friedman J; Slomka P; Heller GV; Germano G; Gosselin G; Berger P; Kostuk WJ; Schwartz RG; Knudtson M; Veledar E; Bates ER; McCallister B; Teo KK; Boden WE;
    Circulation; 2008 Mar; 117(10):1283-91. PubMed ID: 18268144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriate therapy for patients with stable ischemic heart disease: a review of literature and the implication of the International Study of Comparative Effectiveness with Medical and Invasive Approaches trial.
    Guo MH; Nantsios A; Ruel M
    Curr Opin Cardiol; 2020 Nov; 35(6):658-663. PubMed ID: 32941193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Implications of the ISCHEMIA Trial: Invasive vs Conservative Approach in Stable Coronary Disease.
    Choudhary J; Chiu S; Bhugra P; Bikdeli B; Supariwala A; Jauhar R; Chatterjee S
    Curr Cardiol Rep; 2021 Mar; 23(5):43. PubMed ID: 33704597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of the ISCHEMIA Trial on Clinical Practice: an Interventionist's Perspective.
    Mavromatis K; Gershlick A
    Cardiovasc Drugs Ther; 2022 Oct; 36(5):1019-1026. PubMed ID: 34324117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.
    Stone GW; Hochman JS; Williams DO; Boden WE; Ferguson TB; Harrington RA; Maron DJ
    J Am Coll Cardiol; 2016 Jan; 67(1):81-99. PubMed ID: 26616030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Planning and Conducting the ISCHEMIA Trial.
    Maron DJ; Harrington RA; Hochman JS
    Circulation; 2018 Oct; 138(14):1384-1386. PubMed ID: 30354348
    [No Abstract]   [Full Text] [Related]  

  • 13. Myocardial Ischemia in the Management of Chronic Coronary Artery Disease: Past and Present.
    Gibbons RJ
    Circ Cardiovasc Imaging; 2021 Jan; 14(1):e011615. PubMed ID: 33455408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can Functional Testing for Ischemia and Viability Guide Revascularization?
    Mielniczuk LM; Toth GG; Xie JX; De Bruyne B; Shaw LJ; Beanlands RS
    JACC Cardiovasc Imaging; 2017 Mar; 10(3):354-364. PubMed ID: 28279384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA.
    Phillips LM; Hachamovitch R; Berman DS; Iskandrian AE; Min JK; Picard MH; Kwong RY; Friedrich MG; Scherrer-Crosbie M; Hayes SW; Sharir T; Gosselin G; Mazzanti M; Senior R; Beanlands R; Smanio P; Goyal A; Al-Mallah M; Reynolds H; Stone GW; Maron DJ; Shaw LJ
    J Nucl Cardiol; 2013 Dec; 20(6):969-75. PubMed ID: 23963599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization.
    Davies RF; Goldberg AD; Forman S; Pepine CJ; Knatterud GL; Geller N; Sopko G; Pratt C; Deanfield J; Conti CR
    Circulation; 1997 Apr; 95(8):2037-43. PubMed ID: 9133513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons Learned from the ISCHEMIA Trial for the Management of Patients with Stable Ischemic Heart Disease.
    Boden WE; Stone PH
    Annu Rev Med; 2023 Jan; 74():189-198. PubMed ID: 36318679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Patients With Stable Ischemic Heart Disease.
    Civeira F; Mateo-Gallego R
    JAMA; 2016 May; 315(17):1904-5. PubMed ID: 27139069
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of Patients With Stable Ischemic Heart Disease--Reply.
    Bangalore S; Maron DJ; Hochman JS
    JAMA; 2016 May; 315(17):1905-6. PubMed ID: 27139072
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Patients With Stable Ischemic Heart Disease--Reply.
    Polonsky TS; Blankstein R
    JAMA; 2016 May; 315(17):1906-7. PubMed ID: 27139073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.